Clinical & Translational Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2021-03-21 里希特霍芬达

审稿速度:3.0
偏重的研究方向：乳腺癌
经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？

81 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2022-08-25 ms9000001512562379

我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2022-10-25 ms8000000551179908

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问editor assigned状态要持续多久啊？

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2022-10-11 ms8000000524560535

偏重的研究方向：肿瘤;癌症
经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2022-06-08 ms1000001119710084

请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了

29 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2021-11-18 ms9000001676514510

投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？

45 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2020-12-12 1245a12em04(暂无昵称)

攒人品，纯生信，一天秒拒

114 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2021-06-06 ms7000001723077483

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;放疗
经验分享：两天秒拒，没有理由

54 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2019-06-26 phoebeyan520

请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！

155 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=949864, encodeId=198b94986464, content=审稿速度:3.0 偏重的研究方向：乳腺癌 经验分享：我选了OA，但是接收后invoice一个礼拜了还没发来，请问大家的invoice都是多久才收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19f05426867, createdName=里希特霍芬达, createdTime=Sun Mar 21 11:00:40 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241017, encodeId=d326124101ecf, content=我17 Aug 2022提交，22 Aug 2022更新状态为Editor Invited，啥时候会有新进展呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66ee5509295, createdName=ms9000001512562379, createdTime=Thu Aug 25 21:31:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096075, encodeId=9bda20960e595, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问editor assigned状态要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Oct 25 16:47:59 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093190, encodeId=c1182093190ba, content=偏重的研究方向：肿瘤;癌症 经验分享：10月10号，提交 10月11号，AE assigned 接下来还需要经历多久能拿到意见，急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Tue Oct 11 19:40:43 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225234, encodeId=59e01225234bb, content=请问大家，投出去三个多月了，反复的“指派审稿人”“审稿重”什么意思呀？已经重复三次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5a35503965, createdName=ms1000001119710084, createdTime=Wed Jun 08 17:31:53 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071356, encodeId=77ad10e135610, content=投了之后说给介绍期刊转投，1周了没有消息，请问有遇到这种情况的同学吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02925649921, createdName=ms9000001676514510, createdTime=Thu Nov 18 11:02:32 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907209, encodeId=979390e2098c, content=攒人品，纯生信，一天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cfd2480964, createdName=1245a12em04(暂无昵称), createdTime=Sat Dec 12 00:13:53 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971292, encodeId=0f829e12925d, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;放疗 经验分享：两天秒拒，没有理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfa05503873, createdName=ms7000001723077483, createdTime=Sun Jun 06 15:02:22 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572980, encodeId=a3095e298081, content=请问有人遇到不能提交的状态吗？我的状态是“Submissions being processed (1)”,而“Submissions waiting for author’s approval (0)”,而且共同作者很多不能确认利益冲突的那个链接。因为投稿的事情拖了几天，急需文章毕业，所以问问如何解决，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed Jun 26 00:00:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127463, encodeId=9028212e4631c, content=麻烦问下大家都是几天从new submission变成under review的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96762562838, createdName=想想再说, createdTime=Fri Apr 21 11:53:56 CST 2023, time=2023-04-21, status=1, ipAttribution=黑龙江省)]

2023-04-21 想想再说来自黑龙江省

麻烦问下大家都是几天从new submission变成under review的？

31 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务